Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
79,310,345
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
12,425,504
-
Shares change
-
-922,975
-
Total reported value, excl. options
-
$49,348,797
-
Value change
-
-$5,601,808
-
Put/Call ratio
-
200%
-
Number of buys
-
36
-
Number of sells
-
-40
-
Price
-
$4.02
Significant Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q2 2022
98 filings reported holding CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE as of Q2 2022.
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,425,504 shares
of 79,310,345 outstanding shares and own 16% of the company stock.
Largest 10 shareholders include NOMURA HOLDINGS INC (2,952,127 shares), VANGUARD GROUP INC (1,655,006 shares), Elliott Investment Management L.P. (1,550,523 shares), BARCLAYS PLC (750,000 shares), MILLENNIUM MANAGEMENT LLC (686,251 shares), BlackRock Inc. (637,770 shares), GEODE CAPITAL MANAGEMENT, LLC (330,954 shares), Cresset Asset Management, LLC (329,796 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (282,202 shares), and BANK OF MONTREAL /CAN/ (281,600 shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.